Tait Labs awarded support from NRC-IRAP, Bank of Development of Canada and Futurpreneur (formerly CYBF), totalling over $125k
Oct 2012: Andrew Tait wins Innovation Challenge Award
Insights into Viral Mechanisms of Multiple Sclerosis and the Use of a Botanical Extract from Traditional Chinese Medicine to Reverse Demyelination
Andrew Tait’s research has led to a better understanding of the role of the protein U24 in myelin degradation—a key factor in neurodegenerative conditions, such as multiple sclerosis. As a result of this research, he has established a company—Tait Laboratories Inc.—to develop and market plant-based extracts found in traditional Chinese medicine that may potentially help many people suffering from neurodegenerative disease associated with aging and multiple sclerosis.